September 30, 2026

ACCESS Newswire
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis

General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform

IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance

Icarus’ Future: A Miami-Born Campaign Telling COP30 Leaders Our Children’s Future is at Stake – Just Won Seven LUUM Awards

Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions

OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

GA-ASI Completes Full-Scale Fatigue Test on MQ-9B

GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 2026
